Organization: Platform Technology
Location: Singapore
Job Type: Senior Leadership | Full Time
The Nucleic Acid Therapeutics Initiative (NATi), hosted by A*STAR, is Singapore's national platform dedicated to advancing RNA-based medicines and revolutionizing drug and vaccine development.
NATi's mission is to establish Singapore as a globally recognized hub of excellence in nucleic acid therapeutics research, clinical translation, and commercialization.
NATi focuses on key RNA modalities such as antisense oligonucleotides (ASOs), small interfering RNA (siRNA), and messenger RNA (mRNA).
To drive this vision, NATi is building a biotech-like translational engine focused on asset and technology development spanning discovery to clinical development.
We are actively seeking passionate and committed RNA scientists with deep translational expertise to join us in advancing the next generation of RNA-based therapeutics.
The Head of mRNA Platform will build and lead a robust and fully integrated mRNA research organization to support the discovery, production, preclinical development, and translation of mRNA Drug Candidates.
This role demands deep expertise across the different elements of the mRNA technology to ensure readiness and to position the platform to operate as a robust engine for development of mRNA-based medicines.
This leader will work closely with the NATi Managing Director to develop and execute the strategy for the mRNA Platform.
They will establish productive partnerships with the heads of therapeutic areas to collaboratively develop the next wave of mRNA medicines.
Additionally, this leader will play a critical role in defining the innovation agenda for the mRNA platform and oversee strategic partnerships with global collaborators focused on unlocking the full potential of mRNA as a therapeutic modality.
NATi is conducting a global search for top-tier talent in mRNA therapeutics.
We welcome applications from leading scientists and biotech innovators worldwide.
This role provides a highly competitive compensation package aligned with global industry standards, including attractive benefits and long-term career growth opportunities within Singapore's thriving ecosystem.
Join us in shaping the future of RNA-based medicines and establishing Singapore as a world-class hub for nucleic acid therapeutics